Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 4
2014 6
2015 7
2016 9
2017 12
2018 3
2019 8
2020 9
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Results by year
Filters applied: . Clear all
Page 1
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.
Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, Vanni I, Boccardo S, Rijavec E, Genova C, Biello F, Barletta G, Rossi G, Tagliamento M, Maggioni C, Grossi F. Dal Bello MG, et al. Among authors: vanni i. J Transl Med. 2019 Mar 8;17(1):74. doi: 10.1186/s12967-019-1828-0. J Transl Med. 2019. PMID: 30849967 Free PMC article.
Exosomes: a new horizon in lung cancer.
Vanni I, Alama A, Grossi F, Dal Bello MG, Coco S. Vanni I, et al. Drug Discov Today. 2017 Jun;22(6):927-936. doi: 10.1016/j.drudis.2017.03.004. Epub 2017 Mar 10. Drug Discov Today. 2017. PMID: 28288782 Review.
Current State of Target Treatment in BRAF Mutated Melanoma.
Tanda ET, Vanni I, Boutros A, Andreotti V, Bruno W, Ghiorzo P, Spagnolo F. Tanda ET, et al. Among authors: vanni i. Front Mol Biosci. 2020 Jul 14;7:154. doi: 10.3389/fmolb.2020.00154. eCollection 2020. Front Mol Biosci. 2020. PMID: 32760738 Free PMC article. Review.
Understanding the checkpoint blockade in lung cancer immunotherapy.
Dal Bello MG, Alama A, Coco S, Vanni I, Grossi F. Dal Bello MG, et al. Among authors: vanni i. Drug Discov Today. 2017 Aug;22(8):1266-1273. doi: 10.1016/j.drudis.2017.05.016. Epub 2017 Jun 7. Drug Discov Today. 2017. PMID: 28600190 Review.
Efficacy of motesanib diphosphate in non-small-cell lung cancer.
Rijavec E, Genova C, Barletta G, Biello F, Dal Bello MG, Coco S, Truini A, Vanni I, Alama A, Boccardo F, Grossi F. Rijavec E, et al. Among authors: vanni i. Expert Opin Pharmacother. 2014 Aug;15(12):1771-80. doi: 10.1517/14656566.2014.938639. Expert Opin Pharmacother. 2014. PMID: 25032887 Review.
Belagenpumatucel-L for the treatment of non-small cell lung cancer.
Rijavec E, Biello F, Genova C, Barletta G, Maggioni C, Dal Bello MG, Coco S, Truini A, Vanni I, Alama A, Beltramini S, Grassi MA, Boccardo F, Grossi F. Rijavec E, et al. Among authors: vanni i. Expert Opin Biol Ther. 2015;15(9):1371-9. doi: 10.1517/14712598.2015.1073709. Epub 2015 Jul 27. Expert Opin Biol Ther. 2015. PMID: 26211534 Review.
Vinflunine for the treatment of non-small cell lung cancer.
Genova C, Alama A, Coco S, Rijavec E, Dal Bello MG, Vanni I, Biello F, Barletta G, Rossi G, Grossi F. Genova C, et al. Among authors: vanni i. Expert Opin Investig Drugs. 2016 Dec;25(12):1447-1455. doi: 10.1080/13543784.2016.1252331. Epub 2016 Nov 1. Expert Opin Investig Drugs. 2016. PMID: 27771969 Review.
Oral vinorelbine in the treatment of non-small-cell lung cancer.
Barletta G, Genova C, Rijavec E, Burrafato G, Biello F, Sini C, Dal Bello MG, Coco S, Truini A, Vanni I, Alama A, Beltramini S, Grassi MA, Boccardo F, Grossi F. Barletta G, et al. Among authors: vanni i. Expert Opin Pharmacother. 2014 Aug;15(11):1585-99. doi: 10.1517/14656566.2014.934224. Epub 2014 Jun 27. Expert Opin Pharmacother. 2014. PMID: 24972635 Review.
61 results